Consensus statement for the treatment of infantile haemangiomas with propranolol

Sarah L. Smithson, Marius Rademaker, Susan Adams, Stuart Bade, Philip Bekhor, Samantha Davidson, Amanda Dore, Catherine Drummond, Gayle Fischer, Alexander Gin, Claire Grills, Anne Halbert, Zerina Lokmic, Emma McCahon, Vanessa A. Morgan, Dedee F Murrell, David Orchard, Anthony Penington, Diana Purvis, John Relic & 10 others Susan Robertson, Aaron J. Robinson, Laura Scardamaglia, John Su, Swee Tan, Orli Wargon, Lachlan Warren, Li Chuen Wong, Tania Zappala, Roderic Phillips

Research output: Contribution to journalArticleOtherpeer-review

Abstract

Although most infantile haemangiomas do not require treatment due to a natural history of spontaneous involution, some require early intervention. The Australasian Vascular Anomalies Network and the Australasian Paediatric Dermatology Network have developed a consensus statement for the treatment of infantile haemangiomas with oral propranolol. Infants with haemangiomas that are life threatening, at risk of ulceration, or at risk of causing a significant functional impairment, psychological impact or physical deformity should be treated early with oral propranolol. Oral propranolol is safe and effective and in most healthy infants oral propranolol can be started in an outpatient setting.

Original languageEnglish
Pages (from-to)155-159
Number of pages5
JournalAustralasian Journal of Dermatology
Volume58
Issue number2
DOIs
Publication statusPublished - May 2017
Externally publishedYes

Keywords

  • Australian
  • beta-blocker
  • consensus
  • hemangioma
  • infantile haemangioma
  • New Zealand
  • propranolol
  • vascular anomaly

Cite this

Smithson, Sarah L. ; Rademaker, Marius ; Adams, Susan ; Bade, Stuart ; Bekhor, Philip ; Davidson, Samantha ; Dore, Amanda ; Drummond, Catherine ; Fischer, Gayle ; Gin, Alexander ; Grills, Claire ; Halbert, Anne ; Lokmic, Zerina ; McCahon, Emma ; Morgan, Vanessa A. ; Murrell, Dedee F ; Orchard, David ; Penington, Anthony ; Purvis, Diana ; Relic, John ; Robertson, Susan ; Robinson, Aaron J. ; Scardamaglia, Laura ; Su, John ; Tan, Swee ; Wargon, Orli ; Warren, Lachlan ; Wong, Li Chuen ; Zappala, Tania ; Phillips, Roderic. / Consensus statement for the treatment of infantile haemangiomas with propranolol. In: Australasian Journal of Dermatology. 2017 ; Vol. 58, No. 2. pp. 155-159.
@article{b04b73196e464df0bfa64baa2c717c0a,
title = "Consensus statement for the treatment of infantile haemangiomas with propranolol",
abstract = "Although most infantile haemangiomas do not require treatment due to a natural history of spontaneous involution, some require early intervention. The Australasian Vascular Anomalies Network and the Australasian Paediatric Dermatology Network have developed a consensus statement for the treatment of infantile haemangiomas with oral propranolol. Infants with haemangiomas that are life threatening, at risk of ulceration, or at risk of causing a significant functional impairment, psychological impact or physical deformity should be treated early with oral propranolol. Oral propranolol is safe and effective and in most healthy infants oral propranolol can be started in an outpatient setting.",
keywords = "Australian, beta-blocker, consensus, hemangioma, infantile haemangioma, New Zealand, propranolol, vascular anomaly",
author = "Smithson, {Sarah L.} and Marius Rademaker and Susan Adams and Stuart Bade and Philip Bekhor and Samantha Davidson and Amanda Dore and Catherine Drummond and Gayle Fischer and Alexander Gin and Claire Grills and Anne Halbert and Zerina Lokmic and Emma McCahon and Morgan, {Vanessa A.} and Murrell, {Dedee F} and David Orchard and Anthony Penington and Diana Purvis and John Relic and Susan Robertson and Robinson, {Aaron J.} and Laura Scardamaglia and John Su and Swee Tan and Orli Wargon and Lachlan Warren and Wong, {Li Chuen} and Tania Zappala and Roderic Phillips",
year = "2017",
month = "5",
doi = "10.1111/ajd.12600",
language = "English",
volume = "58",
pages = "155--159",
journal = "Australasian Journal of Dermatology",
issn = "0004-8380",
publisher = "Wiley-Blackwell",
number = "2",

}

Smithson, SL, Rademaker, M, Adams, S, Bade, S, Bekhor, P, Davidson, S, Dore, A, Drummond, C, Fischer, G, Gin, A, Grills, C, Halbert, A, Lokmic, Z, McCahon, E, Morgan, VA, Murrell, DF, Orchard, D, Penington, A, Purvis, D, Relic, J, Robertson, S, Robinson, AJ, Scardamaglia, L, Su, J, Tan, S, Wargon, O, Warren, L, Wong, LC, Zappala, T & Phillips, R 2017, 'Consensus statement for the treatment of infantile haemangiomas with propranolol' Australasian Journal of Dermatology, vol. 58, no. 2, pp. 155-159. https://doi.org/10.1111/ajd.12600

Consensus statement for the treatment of infantile haemangiomas with propranolol. / Smithson, Sarah L.; Rademaker, Marius ; Adams, Susan; Bade, Stuart; Bekhor, Philip; Davidson, Samantha; Dore, Amanda; Drummond, Catherine; Fischer, Gayle; Gin, Alexander; Grills, Claire; Halbert, Anne; Lokmic, Zerina; McCahon, Emma; Morgan, Vanessa A.; Murrell, Dedee F; Orchard, David; Penington, Anthony; Purvis, Diana; Relic, John; Robertson, Susan; Robinson, Aaron J.; Scardamaglia, Laura; Su, John; Tan, Swee; Wargon, Orli; Warren, Lachlan; Wong, Li Chuen; Zappala, Tania; Phillips, Roderic.

In: Australasian Journal of Dermatology, Vol. 58, No. 2, 05.2017, p. 155-159.

Research output: Contribution to journalArticleOtherpeer-review

TY - JOUR

T1 - Consensus statement for the treatment of infantile haemangiomas with propranolol

AU - Smithson, Sarah L.

AU - Rademaker, Marius

AU - Adams, Susan

AU - Bade, Stuart

AU - Bekhor, Philip

AU - Davidson, Samantha

AU - Dore, Amanda

AU - Drummond, Catherine

AU - Fischer, Gayle

AU - Gin, Alexander

AU - Grills, Claire

AU - Halbert, Anne

AU - Lokmic, Zerina

AU - McCahon, Emma

AU - Morgan, Vanessa A.

AU - Murrell, Dedee F

AU - Orchard, David

AU - Penington, Anthony

AU - Purvis, Diana

AU - Relic, John

AU - Robertson, Susan

AU - Robinson, Aaron J.

AU - Scardamaglia, Laura

AU - Su, John

AU - Tan, Swee

AU - Wargon, Orli

AU - Warren, Lachlan

AU - Wong, Li Chuen

AU - Zappala, Tania

AU - Phillips, Roderic

PY - 2017/5

Y1 - 2017/5

N2 - Although most infantile haemangiomas do not require treatment due to a natural history of spontaneous involution, some require early intervention. The Australasian Vascular Anomalies Network and the Australasian Paediatric Dermatology Network have developed a consensus statement for the treatment of infantile haemangiomas with oral propranolol. Infants with haemangiomas that are life threatening, at risk of ulceration, or at risk of causing a significant functional impairment, psychological impact or physical deformity should be treated early with oral propranolol. Oral propranolol is safe and effective and in most healthy infants oral propranolol can be started in an outpatient setting.

AB - Although most infantile haemangiomas do not require treatment due to a natural history of spontaneous involution, some require early intervention. The Australasian Vascular Anomalies Network and the Australasian Paediatric Dermatology Network have developed a consensus statement for the treatment of infantile haemangiomas with oral propranolol. Infants with haemangiomas that are life threatening, at risk of ulceration, or at risk of causing a significant functional impairment, psychological impact or physical deformity should be treated early with oral propranolol. Oral propranolol is safe and effective and in most healthy infants oral propranolol can be started in an outpatient setting.

KW - Australian

KW - beta-blocker

KW - consensus

KW - hemangioma

KW - infantile haemangioma

KW - New Zealand

KW - propranolol

KW - vascular anomaly

UR - http://www.scopus.com/inward/record.url?scp=85014009698&partnerID=8YFLogxK

U2 - 10.1111/ajd.12600

DO - 10.1111/ajd.12600

M3 - Article

VL - 58

SP - 155

EP - 159

JO - Australasian Journal of Dermatology

JF - Australasian Journal of Dermatology

SN - 0004-8380

IS - 2

ER -

Smithson SL, Rademaker M, Adams S, Bade S, Bekhor P, Davidson S et al. Consensus statement for the treatment of infantile haemangiomas with propranolol. Australasian Journal of Dermatology. 2017 May;58(2):155-159. https://doi.org/10.1111/ajd.12600